Physician profile
Vincent Jack Rossi
NPI 1013370089
$103,544.02
in general payments reported to CMS, 2019-2025
25 companies · $44K in 2025
The $44K reported for 2025 was more than what 94% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $427 · 2020: $1,628 · 2021: $1,544 · 2022: $2,048 · 2023: $8,143 · 2024: $46K · 2025: $44K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $81K · Travel and Lodging: $12K · Food and Beverage: $5,335 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $120.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $80,882.50 |
| Travel and Lodging | $11,558.39 |
| Food and Beverage | $5,335.24 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $120.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $53,935.51 | 2020-2025 | Excelsiusgps Robotic Navigation System, Xlif, Sable |
| Medtronic, INC. | $20,710.18 | 2024-2025 | Infinity Occipitocervical Upper Thoracic System, Mazor X System, Navlock |
| Spine Wave, INC. | $13,453.50 | 2023-2025 | Salvo Spine System, Spinal Implant, Proficient Posterior Cervical Spine System |
| Vb Spine LLC | $9,650.68 | 2025 | Everest Spinal System, Cascadia Interbody System |
| Stryker Corporation | $1,452.31 | 2019-2025 | Everest Spinal System, Es2 Spinal System, Avs Anchor-L |
| Depuy Synthes Sales INC. | $763.41 | 2019-2025 | Expedium, Symphony, Conduit |
| Peerless Surgical INC. | $740.56 | 2024 | |
| Bioventus LLC | $625.00 | 2024 | |
| Arthrex, INC. | $560.35 | 2024 | |
| Spineart USA INC | $289.30 | 2022-2023 | Perla Tl |
| Nuvasive, INC. | $233.40 | 2022-2023 | Alif, Reline |
| Cerapedics INC. | $199.83 | 2025 | I-Factor Peptide Enhanced Bone Graft |
| Alphatec Spine, INC | $177.80 | 2023 | Lif |
| Relievant Medsystems, INC. | $165.79 | 2019 | |
| Penumbra, INC. | $148.27 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $128.40 | 2021 | |
| Centinel Spine, LLC | $84.63 | 2022 | |
| Providence Medical Technology, INC. | $52.12 | 2023 | |
| Microvention, INC. | $37.12 | 2023 | Web Aneurysm Embolization System, Tubing Kit - Stroke, Stent |
| Aesculap, INC. | $33.80 | 2019-2023 | M.Blue |
| Axogen | $29.34 | 2023 | Avance Nerve Graft |
| Integra Lifesciences Corporation | $20.98 | 2019 | |
| Intrinsic Therapeutics | $20.00 | 2025 | Barricaid Acd (Annular Closure Device) |
| Theragen, INC. | $17.60 | 2023 | Actastim-S |
| Djo, LLC | $14.14 | 2023 | Cmf |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vincent Rossi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.